Financial News · Live Terminal

Page 171 of 377

UBS Lifts Price Target on Omega Healthcare Investors to $54 From $52, Maintains Buy Rating

Omega Healthcare Investors (OHI) has an average rating of overweight and mean price target of $49.94, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $47.61, Change: $-0.04, Percent Change: -0.08%

Financial News · Live Terminal

UBS Lifts Price Target on Omega Healthcare Investors to $54 From $52, Maintains Buy Rating

UBS Adjusts Price Target on Schneider National to $27 From $25, Maintains Neutral Rating

UBS Adjusts Price Target on Healthcare Realty Trust to $20 From $18, Maintains Neutral Rating

UBS Adjusts Price Target on Sabra Health Care REIT to $22 From $21, Maintains Neutral Rating

UBS Adjusts Price Target on Sleep Number to $2 From $4, Maintains Neutral Rating

UBS Trims Price Target on Syndax Pharmaceuticals to $37 From $38, Maintains Buy Rating

UBS Adjusts Price Target on Janus International Group to $6 From $7.25, Maintains Neutral Rating

UBS Cuts Price Target on MercadoLibre to $1,750 From $2,050, Maintains Neutral Rating

UBS Raises Healthpeak Properties Price Target to $19 From $17, Neutral Rating Kept

Planet Labs Unit Signs Two-Year Contract With Czech Agency

UBS Adjusts Aramark Price Target to $56 From $48, Maintains Buy Rating

AngioDynamics Reports 'Durable Oncologic Control' in Study of NanoKnife for Intermediate-Risk Prostate Cancer

UBS Adjusts Price Target on AnaptysBio to $76 From $70, Maintains Buy Rating

UBS Adjusts Price Target on AMN Healthcare Services to $32 From $19.5, Maintains Neutral Rating

Labcorp Holdings Insider Sold Shares Worth $1,502,314, According to a Recent SEC Filing

Truist Lifts Price Target on Target to $123 From $121, Keeps Hold Rating

Truist Cuts Price Target on Lowe's to $280 From $293, Keeps Buy Rating

Instacart Introduces New Advertising Tools for Retail Partners

IBEX Board Approves up to $20 million Stock Buyback Plan

Truist Securities Cuts Price Target on AECOM to $109 From $116, Maintains Buy Rating

UBS Lifts Price Target on Omega Healthcare Investors to $54 From $52, Maintains Buy Rating

UBS Adjusts Price Target on Schneider National to $27 From $25, Maintains Neutral Rating

UBS Adjusts Price Target on Healthcare Realty Trust to $20 From $18, Maintains Neutral Rating

UBS Adjusts Price Target on Sabra Health Care REIT to $22 From $21, Maintains Neutral Rating

UBS Adjusts Price Target on Sleep Number to $2 From $4, Maintains Neutral Rating

UBS Trims Price Target on Syndax Pharmaceuticals to $37 From $38, Maintains Buy Rating

UBS Adjusts Price Target on Janus International Group to $6 From $7.25, Maintains Neutral Rating

UBS Cuts Price Target on MercadoLibre to $1,750 From $2,050, Maintains Neutral Rating

UBS Raises Healthpeak Properties Price Target to $19 From $17, Neutral Rating Kept

Planet Labs Unit Signs Two-Year Contract With Czech Agency

UBS Adjusts Aramark Price Target to $56 From $48, Maintains Buy Rating

AngioDynamics Reports 'Durable Oncologic Control' in Study of NanoKnife for Intermediate-Risk Prostate Cancer

UBS Adjusts Price Target on AnaptysBio to $76 From $70, Maintains Buy Rating

UBS Adjusts Price Target on AMN Healthcare Services to $32 From $19.5, Maintains Neutral Rating

Labcorp Holdings Insider Sold Shares Worth $1,502,314, According to a Recent SEC Filing

Truist Lifts Price Target on Target to $123 From $121, Keeps Hold Rating

Truist Cuts Price Target on Lowe's to $280 From $293, Keeps Buy Rating

Instacart Introduces New Advertising Tools for Retail Partners

IBEX Board Approves up to $20 million Stock Buyback Plan

Truist Securities Cuts Price Target on AECOM to $109 From $116, Maintains Buy Rating